May 29, 2020 -- Cancer biopharmaceutical company CNS Pharmaceuticals has entered into a sponsored research agreement with the University of Texas MD Anderson Cancer Center to investigate cancer treatment technologies.
May 29, 2020 -- Shanghai Cell Therapy Group has partnered with a researcher from the University of Southern California (USC) to develop a way to culture hematopoietic stem and progenitor cells outside of the body.
May 28, 2020 -- A new interactive online tool to track the progress of coronavirus vaccine candidates currently under development has been published by the University of Notre Dame Center for Research Computing.
May 28, 2020 -- A supplier of active pharmaceutical ingredients, CordenPharma, has inked a manufacturing agreement with Moderna. CordenPharma will manufacture large-scale volumes of Moderna's lipid excipient which will be used to manufacture Moderna's SARS-CoV-2 vaccine candidate, mRNA-1273.
May 27, 2020 -- MilliporeSigma and Baylor College of Medicine have announced they are working to advance a vaccine manufacturing platform to fight COVID-19. The partnership will help accelerate the vaccine candidates to phase I clinical trials.
May 27, 2020 -- EdiGene and Immunochina have announced they are collaborating on the development of allogeneic CAR-T therapy for cancer.
May 27, 2020 -- Biopharmaceutical contract development and manufacturing firm Ajinomoto has entered into an agreement with Humanigen for the fill-finish supply of lenzilumab. The drug is being studied in a phase III clinical trial for adult patients hospitalized with COVID-19.
May 27, 2020 -- Artificial intelligence-powered biotech and drug discovery platform AbCellera has closed a $105 million series B financing round to expand its capacity and more.
May 27, 2020 -- Thermo Fisher Scientific has entered into a long-term lease agreement with CSL to operate a new biologics manufacturing facility in Lengnau, Switzerland.
May 26, 2020 -- Merck announced on May 26 that it has entered an agreement to acquire privately held Themis, a company that is developing a vaccine candidate for SARS-CoV-2.
Conferences
AACR Virtual Annual Meeting 2020 II
June 22-24
June 22-24
2nd Annual Cell Therapy Bioprocessing Conference
June 25-26
Boston, Massachusetts United States
June 25-26
Boston, Massachusetts United States
BioProcess International Europe
July 13-16
Amsterdam, Noord-Holland Netherlands
July 13-16
Amsterdam, Noord-Holland Netherlands
Bioprocess International West
August 10-13
Santa Clara, California United States
August 10-13
Santa Clara, California United States
|
General Discussion
|
||
| Topic | Replies / Views | Last Update |
|---|---|---|
|
https://academic.oup.com/ve/pages/coronavirus-evolution
|
0 / 29 | More than 3 days ago |
|
PopSci Hails Impossible Burger 2.0 as Most Important Engineering Innovation in 2019
|
0 / 11 | More than 3 days ago |
|
Engineered Bacteria Produces BeeFree Honey
|
0 / 12 | More than 3 days ago |
|
Consumers' Preference to Buy Unlabeled Produce Increases after Exposure to GMO-labeled Pro
|
0 / 15 | More than 3 days ago |
|
Super-precise new CRISPR tool could tackle a plethora of genetic diseases
|
0 / 14 | More than 3 days ago |
| To see more posts from our community or to share a post of your own, go to our community's forum page. | ||
Insights
Exclusive content for Science Advisory Board members on trends and outcomes that are influencing the future of scientific research.
Communities
Interact with an engaged, global community of your peers who come together to discuss their work and opportunities.
Rewards
Earn points for contributing to research. Redeem your points for merchandise, travel, or even to help your favorite charity.
Connect
